Short Interest in XOMA Co. (NASDAQ:XOMAO) Decreases By 46.1%

XOMA Co. (NASDAQ:XOMAO) was the recipient of a large decline in short interest in June. As of June 15th, there was short interest totaling 1,159 shares, a decline of 46.1% from the May 31st total of 2,149 shares. Based on an average daily volume of 3,451 shares, the days-to-cover ratio is currently 0.3 days.

XOMA Price Performance

NASDAQ XOMAO traded down $0.51 during trading hours on Thursday, hitting $24.96. 13,253 shares of the company were exchanged, compared to its average volume of 4,267. The company has a 50 day moving average of $25.36 and a two-hundred day moving average of $25.42. XOMA has a 52-week low of $24.86 and a 52-week high of $26.40.

XOMA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 14th. Investors of record on Thursday, July 2nd will be paid a dividend of $0.5234 per share. This represents a $2.09 dividend on an annualized basis and a dividend yield of 8.4%. The ex-dividend date is Thursday, July 2nd.

XOMA Company Profile

XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.

In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.